Frontiers | Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management | Neurology
NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies | National Institute on Aging
Current state of Alzheimer's fluid biomarkers | SpringerLink
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation - The Lancet Neurology
Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma | Nature Communications
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia | Journal of Neurology, Neurosurgery & Psychiatry
Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms | HTML
RETISPEC AND TORONTO MEMORY PROGRAM AWARDED GRANT TO LAUNCH INNOVATIVE EARLY DETECTION PROGRAM FOR ALZHEIMER'S IN TORONTO, CANADA
Preclinical markers of neurodegenerative diseases | Download Table
University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation | Alzheimer's Research & Therapy | Full Text
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Frontiers | Ophthalmic Biomarkers for Alzheimer's Disease: A Review | Aging Neuroscience
Molecular pathology of neurodegenerative diseases: principles and practice | Journal of Clinical Pathology
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid* - Molecular & Cellular Proteomics
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases - Mayo Clinic Proceedings
Neurodegenerative disease - Wikipedia
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy | Nature Reviews Neurology
DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease
Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers | Experimental & Molecular Medicine
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study - The Lancet Healthy Longevity
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment: Trends in Pharmacological Sciences
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders | Nature Reviews Neurology
